ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
ASX:IPD
Price:
0.08 AUD
1.27%
Market Closed
Updated:
May 14, 2024
Section:
Relative Value
The Relative Value of one
IPD
stock under the Base Case scenario is
0.05
AUD.
Compared to the current market price of 0.08 AUD,
ImpediMed Ltd
is
Overvalued by 43%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IPD
Relative Value
Base Case
0.05
AUD
Overvaluation 43%
Valuation Multiples
Multiples Across Competitors
IPD Competitors Multiples
ImpediMed Ltd Competitors
ImpediMed Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
ImpediMed Ltd
ASX:IPD
|
161.9m AUD | 15.5 | -8.3 | -6.1 | -6.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.6B USD | 4.5 | 32.2 | 19.1 | 28.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
134.8B USD | 18.4 | 68.1 | 55.6 | 69.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 5.9 | 36.8 | 23.9 | 29.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.9B USD | 3.5 | 26.7 | 14.1 | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.6B USD | 7.2 | 60.4 | 30.4 | 45 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.4B USD | 3.5 | 56.1 | 18.8 | 39.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.8B EUR | 2.7 | 38.8 | 18.6 | 31.3 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
375.2B CNY | 10.4 | 30.8 | 28.4 | 28.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.5B USD | 8.4 | 36.5 | 26.4 | 28.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.5B USD | 13 | 77.5 | 57.9 | 75.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
